Epidemiology of eight common rheumatic diseases in China: A large-scale cross-sectional survey in Beijing

Rheumatology

Volumn 51, Issue 4, 2012, Pages 721-729

  Li, Ru ^a   Sun, Jian ^a   Ren, Li Min ^a   Wang, Hong Yu ^a   Liu, Wen Hong ^a   Zhang, Xue Wu ^a   Chen, Shi ^a   Mu, Rong ^a   He, Jing ^a   Zhao, Yi ^b   Long, Li ^a   Liu, Yan Ying ^a   Liu, Xia ^a   Lu, Xiao Lan ^a   Li, Yu Hui ^a   Wang, Shi Yao ^a   Pan, Si Si ^a   Li, Chun ^a   Wang, Hong Yuan ^c   Li, Zhan Guo ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

China; Prevalence; Rheumatic diseases

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BEHCET DISEASE; BUDD CHIARI SYNDROME; CHINA; CROSS-SECTIONAL STUDY; FEMALE; GOUT; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SCLERODERMA; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; GOUT; HEALTH SURVEYS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; RHEUMATIC DISEASES; SEX DISTRIBUTION; WORLD HEALTH; YOUNG ADULT;

EID: 84863360753     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker370     Document Type: Article

References (99)

1. Helmick CG, Felson DT, Lawrence RC et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008;58: 15-25.
2. Symmons D, Turner G, Webb R et al. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology 2002;41:793-800.
3. Shichikawa K, Inoue K, Hirota S et al. Changes in the incidence and prevalence of rheumatoid arthritis in Kamitonda, Wakayama, Japan, 1965-1996. Ann Rheum Dis 1999;58:751-6.
4. Beasley RP, Bennett PH, Lin CC. Low prevalence of rheumatoid arthritis in Chinese. Prevalence survey in a rural community. J Rheumatol Suppl 1983;10:11-5.
5. Xiang YJ, Dai SM. Prevalence of rheumatic diseases and disability in China. Rheumatol Int 2009;29:481-90.
6. Zeng QY, Chen R, Darmawan J et al. Rheumatic diseases in China. Arthritis Res Ther 2008;10:R17.
7. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
8. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40: 1725.
9. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
10. Yamaguchi M, Ohta A, Tsunematsu T et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-30.
11. Tanimoto K, Nakano K, Kano S et al. Classification criteria for polymyositis and dermatomyositis. J Rheumatol 1995; 22:668-74.
12. Congi L, Roussou E. Clinical application of the CASPAR criteria for psoriatic arthritis compared to other existing criteria. Clin Exp Rheumatol 2010;28:304-10.
13. Criteria for diagnosis of Behcet's disease. International study group for Behcet's disease. Lancet 1990;335: 1078-80.
14. Wigley RD, Zhang NZ, Zeng QY et al. Rheumatic diseases in China: ILAR-China study comparing the prevalence of rheumatic symptoms in northern and southern rural populations. J Rheumatol 1994;21:1484-90.
15. Dai SM, Han XH, Zhao DB et al. Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: a COPCORD study. J Rheumatol 2003;30:2245-51.
16. Chou CT, Pei L, Chang DM et al. Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol 1994;21: 302-6.
17. Lau E, Symmons D, Bankhead C et al. Low prevalence of rheumatoid arthritis in the urbanized Chinese of Hong Kong. J Rheumatol 1993;20:1133-7.
18. Minh HTT, Darmawan J, Chen SL et al. Prevalence of the rheumatic diseases in urban Vietnam: a WHO-ILAR COPCORD study. J Rheumatol 2003;30:2252-6.
19. Darmawan J, Muirden KD, Valkenburg HA et al. The epidemiology of rheumatoid arthritis in Indonesia. Br J Rheumatol 1993;32:537-40.
20. Wigley R, Manahan L, Muirden KD et al. Rheumatic disease in a Philippine village. II: a WHO-ILAR-APLAR COPCORD study, phases II and III. Rheumatol Int 1991; 11:157-61.
21. Farooqi A, Gibson T. Prevalence of the major rheumatic disorders in the adult population of north Pakistan. Br J Rheumatol 1998;37:491-5.
22. Chaiamnuay P, Darmawan J, Muirden KD et al. Epidemiology of rheumatic disease in rural Thailand: a WHO-ILAR COPCORD study. J Rheumatol 1998;25: 1382-7.
23. Al-Awadhi AM, Olusi SO, Moussa M et al. Musculoskeletal pain, disability and health-seeking behavior in adult Kuwaitis using a validated Arabic version of the WHO-ILAR COPCORD Core Questionnaire. Clin Exp Rheumatol 2004;22:177-83.
24. Guillemin F, Saraux A, Guggenbuhl P et al. Prevalene of rheumatoid arthritis in France: 2001. Ann Rheum Dis 2005; 64:1427-30.
25. Carmona L, Villaverde V, Hernandez-Garcia C et al. The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology 2002;41: 88-95.
26. Cimmino MA, Parisi M, Moggiana G et al. Prevalence of rheumatoid arthritis in Italy: the Chiavari study. Ann Rheum Dis 1998;57:315-8.
27. Andrianakos A, Trontzas P, Christoyannis F et al. Prevalence and management of rheumatoid arthritis in the general population of Greece-the ESORDIG study. Rheumatology 2006;45:1549-54.
28. Stojanovic R, Vlajinac H, Palic-Obradovic D et al. Prevalence of RA in Belgrade, Yugoslavia. Br J Rheumatol 1998;37:729-32.
29. Kaçar C, Gilgil E, Tuncer T et al. Prevalence of rheumatoid arthritis in Antalya, Turkey. Clin Rheumatol 2005;24: 212-4.
30. Riise T, Jacobsen BK, Gran JT. Incidence and prevalence of rheumatoid arthritis in the county of Troms, northern Norway. J Rheumatol 2000;27:1386-9.
31. Hakala M, Pollanen R, Nieminen P. The ARA 1987 revised criteria select patients with clinical rheumatoid arthritis from a population based cohort of subjects with chronic rheumatic diseases registered for drug reimbursement. J Rheumatol 1993;20:1674-8.
32. Neovius M, Simard JF, Askling J. Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden. Ann Rheum Dis 2011;70:624-9.
33. Spindler A, Bellomio V, Berman A et al. Prevalence of rheumatoid arthritis in Tucuman, Argentina. J Rheumatol 2002;29:1166-70.
34. Gabriel SE, Crowson CS, O'Fallon WM. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum 1999;42:415-20.
35. Reyes-Llerena GA, Guibert-Toledano M, Penedo-Coello A et al. Community-based study to estimate prevalence and burden of illness of rheumatic diseases in Cuba: a COPCORD study. J Clin Rheumatol 2009;15: 51-5.
36. Peláez-Ballestas I, Sanin LH, Moreno-Montoya J et al. Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology. J Rheumatol 2011;86(Suppl):3-8.
37. Harvey J, Lotze M, Stevens MB et al. Rheumatoid arthritis in a Chippewa Band. I. Pilot screening study of disease prevalence. Arthritis Rheum 1981;24:717-21.
38. Silman AJ, Ollier W, Holligan S et al. Absence of rheumatoid arthritis in a rural Nigerian population. J Rheumatol 1993;20:618-22.
39. Chen S, Du H, Wang Y et al. The epidemiology study of hyperuricemia and gout in a community population of Huangpu District in Shanghai. Chin Med J 1998;111: 228-30.
40. Nan H, Qiao Q, Dong Y et al. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. J Rheumatol 2006;33:1346-50.
41. Zeng Q, Wang Q, Chen R et al. Primary gout in Shantou: a clinical and epidemiological study. Chin Med J 2003;116: 66-9.
42. Chou CT, Lai JS. The epidemiology of hyperuricaemia and gout in Taiwan aborigines. Br J Rheumatol 1998;37: 258-62.
43. Chang HY, Pan WH, Yeh WT et al. Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-96). J Rheumatol 2001;28: 1640-6.
44. Li Y, Stamler J, Xiao Z et al. Serum uric acid and its correlates in Chinese adult populations, urban and rural, of Beijing. The PRC-USA Collaborative Study in Cardiovascular and Cardiopulmonary Epidemiology. Int J Epidemiol 1997;26:288-96.
45. Hakoda M. Epidemiology of hyperuricemia and gout in Japan. Nippon Rinsho 2008;66:647-52.
46. Darmawan J, Valkenburg HA, Muirden KD et al. The epidemiology of gout and hyperuricemia in a rural population of Java. J Rheumatol 1992;19:1595-9.
47. Davatchi F, Jamshidi AR, Banihashemi AT et al. WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran. J Rheumatol 2008;35:1384.
48. Mikuls TR, Farrar JT, Bilker WB et al. Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 2005;64:267-72.
49. Caki{dotless}r N, Pamuk ON, Derviş E et al. The prevalences of some rheumatic diseases in western Turkey: Havsa study. Rheumatol Int 2011, Advance Access published 13 January 2011, doi:10.1007/s00296-010-1699-4.
50. Anagnostopoulos I, Zinzaras E, Alexiou I et al. The prevalence of rheumatic diseases in central Greece: a population survey. BMC Musculoskelet Disord 2010;11:98.
51. Salaffi F, De Angelis R, Grassi W et al. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol 2005;23: 819-28.
52. Tausche AK, Jansen TL, Schröder HE et al. Gout-current diagnosis and treatment. Dtsch Arztebl Int 2009;106: 549-55.
53. Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis 2002; 40:37-42.
54. Klemp P, Stansfield SA, Castle B et al. Gout is on the increase in New Zealand. Ann Rheum Dis 1997;56: 22-6.
55. Minaur N, Sawyers S, Parker J et al. Rheumatic disease in an Australian Aboriginal community in North Queensland, Australia. A WHO-ILAR COPCORD survey. J Rheumatol 2004;31:965-72.
56. Osio-Salido E, Manapat-Reyes H. Epidemiology of systemic lupus erythematosus in Asia. Lupus 2010;19: 1365-73.
57. Al-Arfaj AS, Al-Balla SR, Al-Dalaan AN et al. Prevalence of systemic lupus erythematosus in central Saudi Arabia. Saudi Med J 2002;23:87-9.
58. Malaviya AN, Singh RR, Singh YN et al. Prevalence of systemic lupus erythematosus in India. Lupus 1993;2: 115-8.
59. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006;15:308-18.
60. López P, Mozo L, Gutiérrez C et al. Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus 2003;12:860-5.
61. Nossent HC. Systemic lupus erythematosus in the Arctic region of Norway. J Rheumatol 2001;28:539-46.
62. Nightingale AL, Farmer RD, de Vries CS. Systemic lupus erythematosus prevalence in the UK: methodological issues when using the General Practice Research Database to estimate frequency of chronic relapsing-remitting disease. Pharmacoepidemiol Drug Saf 2007;16:144-51.
63. Ståhl-Hallengren C, Jönsen A, Nived O et al. Incidence studies of systemic lupus erythematosus in southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol 2000;27: 685-91.
64. Govoni M, Castellino G, Bosi S et al. Incidence and prevalence of systemic lupus erythematosus in a district of north Italy. Lupus 2006;15:110-3.
65. Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2002;16:847-58.
66. Bernatsky S, Joseph L, Pineau CA et al. A population-based assessment of systemic lupus erythematosus incidence and prevalence-results and implications of using administrative data for epidemiological studies. Rheumatology 2007;46: 1814-8.
67. Taylor W, Gladman D, Helliwell P et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54: 2665-73.
68. Hukuda S, Minami M, Saito T et al. Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society. J Rheumatol 2001;28:554-9.
69. Saraux A, Guillemin F, Guggenbuhl P et al. Prevalence of spondyloarthropathies in France: 2001. Ann Rheum Dis 2005;64:1431-5.
70. Madland TM, Apalset EM, Johannessen AE et al. Prevalence, disease manifestations, and treatment of psoriatic arthritis in western Norway. J Rheumatol 2005; 32:1918-22.
71. Hellgren L. Association between rheumatoid arthritis and psoriasis in total populations. Acta Rheumatol Scand 1969;15:316-26.
72. van Romunde LK, Valkenburg HA, Swart-Bruinsma W et al. Psoriasis and arthritis. I. A population study. Rheumatol Int 1984;4:55-60.
73. Gelfand JM, Gladman DD, Mease PJ et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005;53:573-7.
74. Soriano ER, Rosa J, Velozo E et al. Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organizationbased study. Rheumatology 2011;50:729-34.
75. Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009;61:1373-8.
76. Gisondi P, Girolomoni G, Sampogna F et al. Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. Eur J Dermatol 2005;15:279-83.
77. Radtke MA, Reich K, Blome C et al. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol 2009;23:683-91.
78. Tam LS, Leung YY, Li EK. Psoriatic arthritis in Asia. Rheumatology 2009;48:1473-7.
79. Nagai M, Fuchigami H, Nishina M et al. Statistics of patients with intractable diseases receiving financial aid for treatment (in Japanese). In: Research Committee on Epidemiology of Intractable Deseases, Ministry of Health and Welfare, ed. Results of Basic Analysis. Tokyo: Japan Government, 2000:64-9.
80. Mahr A, Belarbi L, Wechsler B et al. Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 2008;58:3951-9.
81. Chamberlain MA. Behcet's syndrome in 32 patients in Yorkshire. Ann Rheum Dis 1977;36:491-9.
82. Ek L, Hedfors E. Behcet's disease: a review and a report of 12 cases from Sweden. Acta Derm Venereol 1993;73: 251-4.
83. Salvarani C, Pipitone N, Catanoso MG et al. Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of northern Italy: a seventeen-year population-based study. Arthritis Rheum 2007;57:171-8.
84. Papoutsis NG, Abdel-Naser MB, Altenburg A et al. Prevalence of Adamantiades-Behcet's disease in Germany and the municipality of Berlin: results of a nationwide survey. Clin Exp Rheumatol 2006;24:S125.
85. Calamia KT, Wilson FC, Icen M et al. Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study. Arthritis Rheum 2009;61: 600-4.
86. Robinson D Jr, Eisenberg D, Nietert PJ et al. Systemic sclerosis prevalence and comorbidities in the US, 2001-2002. Curr Med Res Opin 2008;24:1157-66.
87. Roberts-Thomson PJ, Walker JG, Lu TY. Scleroderma in South Australia: further epidemiological observations supporting a stochastic explanation. Int Med J 2006; 489-97.
88. Arias-Nuñez MC, Llorca J, Vazquez-Rodriguez TR et al. Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study. Medicine 2008;87:272-80.
89. Airo P, Tabaglio E, Frassi M et al. Prevalence of systemic sclerosis in Valtrompia in northern Italy. A collaborative study of rheumatologists and general practitioners. Clin Exp Rheumatol 2007;25:878-80.
90. Tamaki T, Mori S, Takehara K. Epidemiological study of patients with systemic sclerosis in Tokyo. Arch Dermatol Res 1991;283:366-71.
91. Allcock RJ, Forrest I, Corris PA et al. A study of the prevalence of systemic sclerosis in northeast England. Rheumatology 2004;43:596-602.
92. Geirsson AJ, Steinsson K, Guthmundsson S et al. Systemic sclerosis in Iceland. A nationwide pidemiological study. Ann Rheum Dis 1994;53:502-5.
93. Le GV, Mahr A, Mouthon L et al. Prevalence of systemic sclerosis in a French multi-ethnic county. Rheumatology 2004;43:1129-37.
94. Radic M, Martinovic KD, Fabijanic D et al. Prevalence of systemic sclerosis in Split-Dalmatia county in southern Croatia. Clin Rheumatol 2010;29:419-21.
95. Rosa JE, Soriano ER, Narvaez-Ponce L et al. Incidence and prevalence of systemic sclerosis in a healthcare plan in Buenos Aires. J Clin Rheumatol 2011;17:59-63.
96. Kusumi M, Nakashima K, Nakayama H et al. Epidemiology of inflammatory neurological and inflammatory neuromuscular diseases in Tottori Prefecture, Japan. Psychiatry Clin Neurosci 1995;49:169-74.
97. Wakai K, Ohta A, Tamakoshi A et al. Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan. J Epidemiol 1997;7:221-5.
98. Bernatsky S, Joseph L, Pineau CA et al. Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences. Ann Rheum Dis 2009;68:1192-6.
99. Evensen KJ, Nossent HC. Epidemiology and outcome of adult-onset Still's disease in Northern Norway. Scand J Rheumatol 2006;35:48-51.